ArticleFrontiers in oncology2026

Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.